Financial reports
10-K
2023 FY
Annual report
20 Feb 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
21 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
Current reports
8-K
Entry into a Material Definitive Agreement
16 Apr 24
8-K
Other Events
31 Jan 24
8-K
Material Modifications to Rights of Security Holders
30 Jan 24
8-K
Entry into a Material Definitive Agreement
11 Jan 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Departure of Directors or Certain Officers
12 Dec 23
8-K
Other Events
26 Oct 23
8-K
Sigyn Therapeutics™ Discloses PCT Patent Submission to Enhance Chemotherapy Delivery and Reduce Cancer Treatment Toxicity
4 Oct 23
8-K
Entry into a Material Definitive Agreement
19 Sep 23
8-K
Entry into a Material Definitive Agreement
7 Jul 23
Registration and prospectus
S-1/A
IPO registration (amended)
10 Apr 24
S-1/A
IPO registration (amended)
22 Sep 23
S-1/A
IPO registration (amended)
10 May 23
S-1/A
IPO registration (amended)
28 Feb 23
S-1/A
IPO registration (amended)
23 Dec 22
S-1/A
IPO registration (amended)
7 Nov 22
S-1/A
IPO registration (amended)
29 Aug 22
S-1
IPO registration
22 Jun 22
D/A
$1.25M in equity / debt / options / securities to be acquired, sold $1.25M, 2 investors
16 Nov 17
424B3
Prospectus supplement
2 Jun 17
Proxies
DEF 14C
Information statement
21 Sep 20
PRE 14C
Preliminary information
9 Sep 20
DEF 14C
Information statement
10 Mar 20
PRE 14C
Preliminary information
25 Feb 20
DEF 14C
Information statement
2 Oct 19
PRE 14C
Preliminary information
17 Sep 19
DEF 14A
Definitive proxy
23 Feb 17
PRE 14A
Preliminary proxy
8 Feb 17
Other
CORRESP
Correspondence with SEC
4 May 16
EFFECT
Notice of effectiveness
4 May 16
CORRESP
Correspondence with SEC
22 Apr 16
UPLOAD
Letter from SEC
4 Mar 16
UPLOAD
Letter from SEC
10 Feb 16
EFFECT
Notice of effectiveness
30 Oct 15
CORRESP
Correspondence with SEC
28 Oct 15
UPLOAD
Letter from SEC
21 Oct 15
UPLOAD
Letter from SEC
1 Oct 15
UPLOAD
Letter from SEC
10 Sep 15
Ownership
SC 13G/A
Brio Capital Master Fund Ltd.
8 Feb 24
SC 13G/A
Brio Capital Master Fund Ltd.
4 Feb 22
SC 13G/A
Brio Capital Master Fund Ltd.
27 Jan 21
SC 13G/A
ALPHA CAPITAL ANSTALT
14 Jan 21
SC 13G
Osher Capital Partners LLC
29 Oct 20
SC 13G/A
Reign Sapphire Corp
4 Feb 20
SC 13G/A
Reign Sapphire Corp
4 Feb 19
SC 13G/A
Reign Sapphire Corp
16 Nov 18
SC 13G
Reign Sapphire Corp
2 Mar 18
SC 13G/A
Reign Sapphire Corp
26 Jan 18